Rare case scenario when you’ll see so HUGE number of “securities class actions” and “class lawsuits” filings from well-known law firms against micro-cap company. Still curious what are reasons for? Let’s look at latest AMRS activities… In press-release from April 18th 2019 Amyris announced that company assigned right to Vitamin E royalties to DSM in […]